06:39 AM EDT, 05/09/2024 (MT Newswires) -- Haemonetics ( HAE ) reported fiscal Q4 adjusted earnings Thursday of $0.90 per diluted share, up from $0.77 a year earlier.

Analysts polled by Capital IQ expected $0.89.

Revenue for the quarter ended March 30 was $343.3 million, compared with $304.4 million a year earlier.

Analysts surveyed by Capital IQ expected $329.5 million.

The company expects fiscal year 2025 adjusted earnings of $4.45 to $4.75 per diluted share. Analysts polled by Capital IQ expect $4.40.